09:15 - 09:45 Registration
09:45 - 10:00 Welcome and opening, Grisha Domakowski, Barcelona Science Park Commercialization & Communication director and Bruce Hamilton, director of Drug Development and Regulatory Strategy at LabCorp
10:00 - 10:30 Tiered De-risking Strategies for NCEs in Drug Development by John Kendrick, Director of Global Metabolism (LabCorp)
10:30 -11:00 Navigating your drug development journey: Non-clinical strategies to optimize success by Bruce Hamilton
11:00 - 11:30 Coffee break
11:30 - 12:00 Analytical derisking (TBC) by Christopher Cooper, UK Science lead - Immunology & Immunotoxicology (LabCorp)
12:00 - 12:30 Derisking strategies for candidate selection - the Almirall experience- by Almirall
12:30 - 13:00 Panel discussion on derisking, All presenters
13:00 - 14:30 Lunch & networking
